O2O Plastic Surgery Appointment Platform 'Soyoung' Wins USD 70 Mln Series E

36Kr.com, 9/04/18

Beijing-based Xinyang Technology, operator of online and mobile O2O plastic surgery appointment booking platform Soyoung.com, announced today the completion of USD 70 mln in Series E funding led by Orchid Asia Group Management with participation from BOC International, Russia-China Investment Fund, and Matrix Partners China, making Soyoung a unicorn in the field of internet healthcare.

With cosmetic surgery as its base, Soyoung plans to gradually expand into other consumer medical fields, such as dentistry, dermatology, and physical exams.

Soyoung's new media presence, including an official account on Tencent's (0700.HK) WeChat mobile messaging app and short videos, has reached a volume of 300 mln video plays and article views per month. The company's online plastic surgery booking gross merchandise volume surpassed RMB 6 bln in 2017, up 300% YoY.

Editor's Note: For more information on this topic, please see Update: O2O Plastic Surgery Appointment Platform 'Soyoung' Raises RMB 200 Mln Series D2, MD 3/16/18 issue.

Keywords: VC Internet funding Orchid Asia BOC International Matrix Partners Series E O2O Soyoung Xinyang Technology Russia-China Investment Fund online healthcare

Feedback

Sending

Disclaimer

The information contained in this newsletter is based upon sources that Marbridge Consulting believes to be reliable, and we have made every effort to translate the original articles or article excerpts as faithfully as possible. However, Marbridge Consulting makes no warranty of and assumes no legal responsibility for the accuracy of either the original source material or the English language translations.

Marbridge Daily